Cancer
Contributor(s): Bradbury, Robert H [editor.] | SpringerLink (Online service).
Material type:
BookSeries: Topics in Medicinal Chemistry: 1Publisher: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2007.Description: XIV, 452 p. 32 illus., 4 illus. in color. online resource.Content type: text Media type: computer Carrier type: online resourceISBN: 9783540331209.Other title: With contributions by numerous experts.Subject(s): Chemistry | Molecular biology | Pharmacology | Organic chemistry | Medicinal chemistry | Chemistry | Medicinal Chemistry | Pharmacology/Toxicology | Organic Chemistry | Molecular MedicineDDC classification: 615.19 Online resources: Click here to access online
Contents:
In:
Springer eBooks
Overview -- Anti-hormone Therapy: Principles of Endocrine Therapy of Cancer -- Inhibition of Growth Factor Signaling by Small-Molecule Inhibitors of ErbB, Raf, and MEK -- Farnesyl Protein Transferase Inhibitors: Medicinal Chemistry, Molecular Mechanisms, and Progress in the Clinic -- Survival Signaling -- Progress in the Development of Agents to Control the Cell Cycle -- HDAC Inhibition in Cancer Therapy: An Increasingly Intriguing Tale of Chemistry, Biology and Clinical Benefit -- Development of Angiogenesis Inhibitors to Vascular Endothelial Growth Factor Receptor 2 for Cancer Therapy -- Novel Small-Molecule Inhibitors of Src Kinase for Cancer Therapy -- Bcr-Abl Kinase Inhibitors.
| Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
E books
|
PK Kelkar Library, IIT Kanpur | Available | EBK9592 |
Total holds: 0
Overview -- Anti-hormone Therapy: Principles of Endocrine Therapy of Cancer -- Inhibition of Growth Factor Signaling by Small-Molecule Inhibitors of ErbB, Raf, and MEK -- Farnesyl Protein Transferase Inhibitors: Medicinal Chemistry, Molecular Mechanisms, and Progress in the Clinic -- Survival Signaling -- Progress in the Development of Agents to Control the Cell Cycle -- HDAC Inhibition in Cancer Therapy: An Increasingly Intriguing Tale of Chemistry, Biology and Clinical Benefit -- Development of Angiogenesis Inhibitors to Vascular Endothelial Growth Factor Receptor 2 for Cancer Therapy -- Novel Small-Molecule Inhibitors of Src Kinase for Cancer Therapy -- Bcr-Abl Kinase Inhibitors.
There are no comments for this item.